Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jasem Youssef Al-Hashel"'
Publikováno v:
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background Coronavirus disease-19 is caused by the severe acute respiratory syndrome coronavirus 2 Headache is a common symptom during and after Coronavirus disease-19. We aimed to study headache character in relation to COVID-19. Methods Th
Externí odkaz:
https://doaj.org/article/c6022d08382d4b3bb6bfff421e83940c
Autor:
Jasem Youssef Al-Hashel, Hasan Kh Ashkanani, Ohood Almutairi, Fajer A. Bokubar, Shahad Mubarak, Sawsan Alwazzan, Raed Alroughani, Doaa Youssry, Samar Farouk Ahmed
Publikováno v:
Frontiers in Neurology, Vol 11 (2021)
Background: Chronic migraine (CM) affects 5.4% of the Kuwaiti population. It is associated with significant headache-related disability, psychiatric comorbidity and reduced quality of life. The aim of this study is to assess the efficacy of Onabotuli
Externí odkaz:
https://doaj.org/article/45a54aca4ad54db6a7a9366bbaca5113
Autor:
Jasem Youssef Al-Hashel, Ismail Ibrahim Ismail, Mohamed Ibrahim, John K. John, Fatemah Husain, Walaa Ahmed Kamel, Raed Behbehani, Samar Farouk Ahmed
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Background: Idiopathic intracranial hypertension (IIH) affects predominantly obese females during their reproductive age period. The demographics of this condition has not been studied in Kuwait before.Objectives: To determine the demographics, clini
Externí odkaz:
https://doaj.org/article/18de0e0eb8bb44c288cd5e763a6b7c81
Publikováno v:
Case Reports in Neurological Medicine, Vol 2019 (2019)
Background. Extramedullary hematopoiesis (EMH) is one of the rare causes of spinal cord compression (SCC). It results from noncancerous proliferation of hematopoietic tissue outside the bone marrow as a compensatory mechanism for ineffective erythrop
Externí odkaz:
https://doaj.org/article/0c55fc77740a471684a799d90eb76cde
Publikováno v:
Acta neurologica Belgica. 121(6)
Edaravone is a free radical scavenger that has been recently approved for treatment of Amyotrophic lateral sclerosis (ALS) to delay functional decline. We aim to evaluate edaravone efficacy and safety in ALS patients in the main neurology tertiary ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::af3bd4e3703d8e69c8c5dd6bd0d88459
https://pubmed.ncbi.nlm.nih.gov/32651875
https://pubmed.ncbi.nlm.nih.gov/32651875